128 related articles for article (PubMed ID: 10488417)
41. Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma.
Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N
Chin Med J (Engl); 2000 Oct; 113(10):889-93. PubMed ID: 11775834
[TBL] [Abstract][Full Text] [Related]
42. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T
Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678
[TBL] [Abstract][Full Text] [Related]
43. Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon.
Bartkova J; Thullberg M; Slezak P; Jaramillo E; Rubio C; Thomassen LH; Bartek J
Gastroenterology; 2001 Jun; 120(7):1680-8. PubMed ID: 11375949
[TBL] [Abstract][Full Text] [Related]
44. Loss of p16 and p27 is associated with progression of human gastric cancer.
Myung N; Kim MR; Chung IP; Kim H; Jang JJ
Cancer Lett; 2000 May; 153(1-2):129-36. PubMed ID: 10779641
[TBL] [Abstract][Full Text] [Related]
45. Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study.
Malusecka E; Zborek A; Krzyzowska-Gruca S
Folia Histochem Cytobiol; 1999; 37(1):19-24. PubMed ID: 10091946
[TBL] [Abstract][Full Text] [Related]
46. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
47. Expression of p16 and cyclin-dependent kinase 4 proteins in primary breast carcinomas.
Ito Y; Kobayashi T; Takeda T; Nakano Y; Tamaki Y; Komoike Y; Wakasugi E; Shin E; Takatsuka Y; Kikkawa N; Matsuura N; Monden M
Oncology; 1997; 54(6):508-15. PubMed ID: 9394849
[TBL] [Abstract][Full Text] [Related]
48. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.
Simpson DJ; Frost SJ; Bicknell JE; Broome JC; McNicol AM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Aug; 22(8):1149-54. PubMed ID: 11470742
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas.
Kim H; Ham EK; Kim YI; Chi JG; Lee HS; Park SH; Jung YM; Myung NK; Lee MJ; Jang JJ
Cancer Lett; 1998 Sep; 131(2):177-83. PubMed ID: 9851251
[TBL] [Abstract][Full Text] [Related]
50. Alteration of the CDKN2/p16 gene is not required for HPV-positive uterine cervical cancer cell lines.
Yoshinouchi M; Hongo A; Takamoto N; Ono Y; Nagao S; Miyagi Y; Kudo T; Kodama J
Int J Oncol; 2000 Mar; 16(3):537-41. PubMed ID: 10675486
[TBL] [Abstract][Full Text] [Related]
51. A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers.
Lingfei K; Pingzhang Y; Zhengguo L; Jianhua G; Yaowu Z
Cancer Lett; 1998 Aug; 130(1-2):93-101. PubMed ID: 9751261
[TBL] [Abstract][Full Text] [Related]
52. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
Reiter FP; Denk G; Ziesch A; Ofner A; Wimmer R; Hohenester S; Schiergens TS; Spampatti M; Ye L; Itzel T; Munker S; Teufel A; Gerbes AL; Mayerle J; De Toni EN
Cell Oncol (Dordr); 2019 Oct; 42(5):705-715. PubMed ID: 31250364
[TBL] [Abstract][Full Text] [Related]
53. [Expression and regulation of p16 in osteosarcoma].
Shi X; Ma Z; Wang D; Liang Y; Li H; Wang J
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):733-6. PubMed ID: 11829939
[TBL] [Abstract][Full Text] [Related]
54. [The expressions of p16, CDK4 and PCNA proteins in trophoblastic tumors].
Fu C; Zhang Q; Lu F; Zhang Z; Hu Y; Lin L
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):17-20. PubMed ID: 10681785
[TBL] [Abstract][Full Text] [Related]
55. Aberrant p16INK4A RNA transcripts expressed in hepatocellular carcinoma cell lines regulate pRb phosphorylation by binding with CDK4, resulting in delayed cell cycle progression.
Cho JW; Jeong YW; Han SW; Park JB; Jang BC; Baek WK; Kwon TK; Park JW; Kim SP; Suh MH; Suh SI
Liver Int; 2003 Jun; 23(3):194-200. PubMed ID: 12955883
[TBL] [Abstract][Full Text] [Related]
56. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung.
Xue Q; Sano T; Kashiwabara K; Oyama T; Nakajima T
Jpn J Cancer Res; 2001 Mar; 92(3):285-92. PubMed ID: 11267938
[TBL] [Abstract][Full Text] [Related]
57. Altered expression of G1 regulatory proteins in human soft tissue sarcomas.
Yoo J; Park SY; Kang SJ; Shim SI; Kim BK
Arch Pathol Lab Med; 2002 May; 126(5):567-73. PubMed ID: 11958662
[TBL] [Abstract][Full Text] [Related]
58. Role of CDK4 and p16INK4A in interleukin-6-mediated growth of multiple myeloma.
Urashima M; Teoh G; Ogata A; Chauhan D; Treon SP; Hoshi Y; DeCaprio JA; Anderson KC
Leukemia; 1997 Nov; 11(11):1957-63. PubMed ID: 9369432
[TBL] [Abstract][Full Text] [Related]
59. Combined analysis of p53 and RB pathways in epithelial ovarian cancer.
Hashiguchi Y; Tsuda H; Yamamoto K; Inoue T; Ishiko O; Ogita S
Hum Pathol; 2001 Sep; 32(9):988-96. PubMed ID: 11567230
[TBL] [Abstract][Full Text] [Related]
60. Expression of pRb and p16INK4 in human thymic epithelial tumors in relation to the presence of human polyomavirus 7.
Keijzers M; Rensspiess D; Pujari S; Abdul-Hamid MA; Hochstenbag M; Dingemans AM; Kurz AK; Haugg A; Maessen JG; De Baets MH; Zur Hausen A
Diagn Pathol; 2015 Nov; 10():201. PubMed ID: 26537237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
